Home › Funds › BAKER BROS. ADVISORS LP › ACAD

BAKER BROS. ADVISORS LP position in ACAD

ACADIA PHARMACEUTICALS INC · Health Care

BAKER BROS. ADVISORS LP reported holding 42,912,904 shares of ACAD (ACADIA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$1.09B, representing 5.68% of its reported portfolio and ranking #5 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed ACAD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)42.91M sh
Reported value held$1.09B
Portfolio Weight5.68%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's ACAD position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in ACAD in Q3 2023 at 42,864,612 shares (US$893.3M). The position peaked in Q4 2023 at 42,864,612 shares, worth US$1.34B. Across 12 filings, BAKER BROS. ADVISORS LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 42,912,904 shares valued at US$1.09B.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 42.86M $893.30M New
Q4 2023 42.86M $1.34B Hold
Q1 2024 42.86M $792.57M Hold
Q2 2024 42.88M $696.77M Hold
Q3 2024 42.88M $659.46M Hold
Q4 2024 42.88M $786.81M Hold
Q1 2025 42.88M $712.20M Hold
Q2 2025 42.90M $925.28M Hold
Q3 2025 42.90M $915.42M Hold
Q4 2025 42.90M $1.15B Hold
Q1 2026 42.90M $954.88M Hold
Q2 2026 42.91M $1.09B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACAD and 13F data

ACAD (ACADIA PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in ACAD — the largest reported positions include RTW INVESTMENTS, LP (US$180.8M), Palo Alto Investors LP (US$72.5M), BRAIDWELL LP (US$41.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACAD

All ACAD fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held ACAD?

BAKER BROS. ADVISORS LP has disclosed ACAD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in ACAD?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 42.91M shares of ACAD (ACADIA PHARMACEUTICALS INC), valued at $1.09B, representing 5.68% of its reported portfolio and ranking #5.

Has BAKER BROS. ADVISORS LP been buying or selling ACAD?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in ACAD. The position peaked in Q4 2023 at 42.86M shares.

Which other funds hold ACAD?

Other major institutional holders of ACAD include RTW INVESTMENTS, LP, Palo Alto Investors LP, BRAIDWELL LP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.